Published in BMC Infect Dis on February 16, 2016
HIV-associated malignancies in sub-Saharan Africa: progress, challenges, and opportunities. Curr Opin HIV AIDS (2017) 0.90
Clinical and computed tomography findings in Chinese lung cancer patients with HIV infection: A multi-center study. Thorac Cancer (2017) 0.75
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst (2005) 6.69
Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer (2008) 6.13
Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med (2006) 5.49
Annual report on status of cancer in China, 2010. Chin J Cancer Res (2014) 4.69
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis (2011) 3.85
Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst (2000) 3.47
AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst (2007) 3.28
Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States. J Clin Oncol (2015) 2.40
Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS (2008) 2.14
Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis (2010) 1.78
The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis (2012) 1.62
Risk of cancer in people with AIDS. AIDS (1999) 1.47
Late diagnosis of HIV infection: major consequences and missed opportunities. Curr Opin Infect Dis (2008) 1.40
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. Clin Infect Dis (2013) 1.31
Cancer screening in patients infected with HIV. Curr HIV/AIDS Rep (2011) 1.21
AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment. AIDS (2009) 1.17
Baseline CD4 cell counts of newly diagnosed HIV cases in China: 2006-2012. PLoS One (2014) 1.10
Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation. Curr Opin HIV AIDS (2009) 1.08
High cancer-related mortality in an urban, predominantly African-American, HIV-infected population. AIDS (2013) 0.99
The changing face of HIV care: common things really are common. Ann Intern Med (2006) 0.94
Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group. J Acquir Immune Defic Syndr (1999) 0.92
Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study. PLoS One (2014) 0.92
Non-AIDS-defining cancers among HIV-infected people. Eur Rev Med Pharmacol Sci (2012) 0.91
A Population-Level Evaluation of the Effect of Antiretroviral Therapy on Cancer Incidence in Kyadondo County, Uganda, 1999-2008. J Acquir Immune Defic Syndr (2015) 0.90
Cancer in cohort of HIV-infected population: prevalence and clinical characteristics. J Cancer Res Clin Oncol (2010) 0.84
Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies. Int J Cancer (2011) 0.84
Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort. Int J Cancer (2015) 0.80
Non-AIDS defining cancers. Med Health R I (2010) 0.77
Trends in first-line antiretroviral therapy in Asia: results from the TREAT Asia HIV observational database. PLoS One (2014) 0.98
Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival. PLoS One (2016) 0.77
Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings. AIDS Res Ther (2017) 0.75
Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific. PLoS One (2016) 0.75
Effects of unplanned treatment interruptions on HIV treatment failure - results from TAHOD. Trop Med Int Health (2016) 0.75
Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings. AIDS Res Ther (2017) 0.75
Weight changes, metabolic syndrome and all-cause mortality among Asian adults living with HIV. HIV Med (2021) 0.75